Cart
sales@molnova.com
Anisperimus
CAS No. 170368-04-4
Anisperimus( —— )
Catalog No. M34502 CAS No. 170368-04-4
Anisperimus (LF 15-0195) is an immunosuppressant that enhances activation-induced T-cell death by promoting caspase-8 and caspase-10 activation at the DISC level, and prevents CNS autoimmunity by promoting the development of Foxp3-expressing regulatory CD4 T cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 962 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAnisperimus
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnisperimus (LF 15-0195) is an immunosuppressant that enhances activation-induced T-cell death by promoting caspase-8 and caspase-10 activation at the DISC level, and prevents CNS autoimmunity by promoting the development of Foxp3-expressing regulatory CD4 T cells.
-
DescriptionAnisperimus (LF 15-0195) is an immunosuppressant that enhances activation-induced T-cell death by promoting caspase-8 and caspase-10 activation at the DISC level, and prevents CNS autoimmunity by promoting the development of Foxp3-expressing regulatory CD4 T cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCaspase
-
RecptorCaspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number170368-04-4
-
Formula Weight401.55
-
Molecular FormulaC18H39N7O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(COC(NCCCCNCC[C@@H](C)N)=O)(NCCCCCCNC(=N)N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Abrine
Abrine exhibits inhibition of rabbit small intestine indoleamine 2, 3-dioxygenase, competitive inhibition of IDO.
-
CIL62 B
CIL62 is a Necrostatin-1 dependent inducer of cell death through a caspase-3/7-independent mechanism .
-
Emricasan
Emricasan (IDN-6556;PF-03491390) is a potent, irreversible pan-caspase inhibitor, shows neuroprotective activity for hNPCs, inhibits ZIKV-induced increased caspase-3 activity.
